Loading the section…
Up to five U.S. securities side by side.
| Metric | HBIOHarvard Bioscience, Inc. |
|---|---|
| Price | 8.85 |
| Change | +0.57 % |
| Return, 1 year | +94.05 % |
| Market capitalisation | 39M |
| Price / earnings | — |
| Price / sales | 0.4 |
| Price / book | 5.3 |
| Enterprise value / EBITDA | — |
| Return on equity | −140.36 % |
| Net margin | −11.86 % |
| Revenue, last year | 88M |
| Net income, last year | −10M |
| Revenue growth, year over year | −1.06 % |
| Debt / equity | — |
| Volatility, 30 days | 24.59 % |
| Beta | 1.26 |
| Sector | Health care |
Data: US exchange trading and company filings with the regulator